Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Apr 20:13:1157010.
doi: 10.3389/fcimb.2023.1157010. eCollection 2023.

Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis

Dan Li  1   2   3 , Xiangning Huang  2 , Huayun Rao  3 , Hua Yu  2 , Shanshan Long  2 , Yulian Li  4 , Jie Zhang  2
Affiliations
Meta-Analysis

Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis

Dan Li et al. Front Cell Infect Microbiol. .

Abstract

Objective: To analyze the mortality rate of patients with Klebsiella pneumoniae bacteremia (KPB) and the impact of extended spectrum beta-lactamase (ESBL) producing or carbapenem-resistance (CR) KP on the mortality rate among patients with bacteremia.

Methods: EMbase, Web of Science, PubMed, and The Cochrane Library were searched up to September 18th, 2022. Two reviewers independently extracted data and evaluated risk of bias of included studies by ROBINS-I tool. A meta-regression analysis was conducted using a mixed-effects model to explore possible sources of heterogeneity. A random-effects model was used for pooled analysis in case of significant heterogeneity (I2>50%). Otherwise, the fixed-effects model was performed.

Results: A total of 157 studies (37,915 enrolled patients) were included in the meta-analysis. The pooled death proportions of KPB were 17% (95% CI=0.14-0.20) at 7-day, 24% (95% CI=0.21-0.28) at 14-day, 29% (95% CI=0.26-0.31) at 30-day, 34% (95% CI=0.26-0.42) at 90-day, and 29% (95% CI=0.26-0.33) in hospital, respectively. Heterogeneity was found from the intensive care unit (ICU), hospital-acquired (HA), CRKP, and ESBL-KP in the meta-regression analysis. More than 50% of ICU, HA, CRKP, and ESBL-KP were associated with a significant higher 30-day mortality rates. The pooled mortality odds ratios (ORs) of CRKP vs. non-CRKP were 3.22 (95% CI 1.18-8.76) at 7-day, 5.66 (95% CI 4.31-7.42) at 14-day, 3.87 (95% CI 3.01-3.49) at 28- or 30-day, and 4.05 (95% CI 3.38-4.85) in hospital, respectively.

Conclusions: This meta-analysis indicated that patients with KPB in ICU, HA-KPB, CRKP, and ESBL-KP bacteremia were associated with a higher mortality rate. The high mortality rate caused by CRKP bacteremia has increased over time, challenging the public health.

Keywords: Klebsiella pneumoniae; bacteremia; carbapenem-resistant; meta-analysis; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow of diagram of meta-analysis generated by PRISMA2020.
Figure 2
Figure 2
Forest plot of single proportion 30-day mortality for KPB.
Figure 3
Figure 3
Forest plot of 30-day mortality for CRKP vs non-CRKP KPB.
See this image and copyright information in PMC

References

    1. Bai A. D., Lo C. K., Komorowski A. S., Suresh M., Guo K., Garg A., et al. . (2022). Staphylococcus aureus bacteremia mortality: a systematic review and meta-analysis. Clin. Microbiol. Infect. 28 (8), 1076–1084. doi: 10.1016/j.cmi.2022.03.015 - DOI - PubMed
    1. Balkan I. I., Alkan M., Aygun G., Kuskucu M., Ankarali H., Karagoz A., et al. . (2021). Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant klebsiella pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 40 (10), 2161–2170. doi: 10.1007/s10096-020-04124-y - DOI - PubMed
    1. Bonten M., Johnson J. R., van den Biggelaar A. H. J., Georgalis L., Geurtsen J., de Palacios P. I., et al. . (2021). Epidemiology of escherichia coli bacteremia: a systematic literature review. Clin. Infect. Dis. 72 (7), 1211–1219. doi: 10.1093/cid/ciaa210 - DOI - PubMed
    1. Castanheira M., Deshpande L. M., Mendes R. E., Canton R., Sader H. S., Jones R. N. (2019). Variations in the occurrence of resistance phenotypes and carbapenemase genes among isolates in 20 years of the SENTRY antimicrobial surveillance program. Open Forum Infect. Dis. 6 (Suppl 1), S23–S33. doi: 10.1093/ofid/ofy347 - DOI - PMC - PubMed
    1. CDC (2022). Available at: https://www.cdc.gov/drugresistance/national-estimates.html.

Publication types

LinkOut - more resources